NCT00074191View on ClinicalTrials.gov

Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

October 31, 2000

Study Completion Date

October 31, 2000

Conditions
Lymphoma
Interventions
DRUG

cytarabine

DRUG

dexamethasone

DRUG

lomustine

DRUG

methotrexate

DRUG

procarbazine hydrochloride

Trial Locations (1)

97239-3098

Oregon Health & Science University Cancer Institute, Portland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

OHSU Knight Cancer Institute

OTHER

NCT00074191 - Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma | Biotech Hunter | Biotech Hunter